发明公开
EP2646008A1 TRANSDERMALES THERAPEUTISCHES SYSTEM (TTS) ENTHALTEND ROTIGOTIN
审中-公开
经皮治疗系统（TTS），罗替戈汀，其包括
- 专利标题： TRANSDERMALES THERAPEUTISCHES SYSTEM (TTS) ENTHALTEND ROTIGOTIN
- 专利标题（英）： Transdermal therapeutic system (tts) comprising rotigotine
- 专利标题（中）： 经皮治疗系统（TTS），罗替戈汀，其包括
-
申请号： EP11790776.6申请日： 2011-11-29
-
公开(公告)号： EP2646008A1公开(公告)日： 2013-10-09
- 发明人: DRESCHER, Christian , JANSSEN, Christian , BECKER, Ulrich , BREITENBACH, Armin
- 申请人： Ratiopharm GmbH
- 申请人地址： Graf-Arco-Strasse 3 89079 Ulm DE
- 专利权人： Ratiopharm GmbH
- 当前专利权人： Ratiopharm GmbH
- 当前专利权人地址： Graf-Arco-Strasse 3 89079 Ulm DE
- 代理机构： Eder, Michael
- 优先权： EP10015079 20101129; US419070P 20101202
- 国际公布： WO2012072650 20120607
- 主分类号： A61K9/70
- IPC分类号： A61K9/70 ; A61K31/381 ; A61K31/00
摘要：
The present invention relates to a patch which comprises the active ingredient rotigotine and is intended for transdermal delivery of the active pharmaceutical ingredient rotigotine, comprising a backing layer (1), a matrix layer (2) which comprises the active ingredient, and a removable protective sheet (4) which is intended for removal before the patch is applied to the skin, characterized in that disposed with areal coverage between the matrix layer (2) and the removable protective sheet (4) is an additional interlayer (3).
信息查询
